| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/13/2001 | CN1299289A Use of an adhesive composition over a bioactive polymerization initiator or accelerator |
| 06/13/2001 | CN1299286A Use of protease inhibitors for treating skin wounds |
| 06/13/2001 | CN1299285A Recombinant human interferon beta-1A (IFN-beta-1A) formulation |
| 06/13/2001 | CN1299277A Pharmaceutical compositions contg. the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy] acetate |
| 06/13/2001 | CN1299273A Sticking plaster for controlled release of natural interferon |
| 06/13/2001 | CN1299272A Method and device for modulating the immune response |
| 06/13/2001 | CN1299257A Use of corneal hardening agent in enzyme orthokeratology |
| 06/13/2001 | CN1299235A Novel composition of eprosartan |
| 06/13/2001 | CN1299234A Method and compounds for the genetic treatment of hyperlipidemia |
| 06/13/2001 | CN1298874A Non-ball shaped and non-flake type mercapto pyridine oxide salts and preph. method therefor |
| 06/13/2001 | CN1298871A 3-(fatty acid)-1,2 glceride disulfate and its preparing process and application |
| 06/13/2001 | CN1298738A Process for preparing gingko injection |
| 06/13/2001 | CN1298737A Medical pill for treating hepattis and its preparing process |
| 06/13/2001 | CN1298733A Powder medicine 'Zhuyushengxin San' for treating stasis |
| 06/13/2001 | CN1298732A Ointment for treating burn and scald and its preparing process |
| 06/13/2001 | CN1298731A Process for preparing 'Qianjin' capsule to treat ganopathy |
| 06/13/2001 | CN1298730A Process for preparing 'Qianjin' capsule to treat genopathy |
| 06/13/2001 | CN1298727A Plaster for treating hyperosteogeny |
| 06/13/2001 | CN1298726A Process for preparing Chinese-medicinal fresh pieces |
| 06/13/2001 | CN1298725A Ointment for treating burn and scald and its preparing process |
| 06/13/2001 | CN1298712A Plaster for treating arthritis, injury, mastitis, sore and furuncle and its preparing process |
| 06/13/2001 | CN1298710A Process for preparing exterior-applied plaster |
| 06/13/2001 | CN1298706A Kelarmycin eye drops and its preparing process |
| 06/13/2001 | CN1298705A Chinese medicine for treating hepatitis B and its preparing process |
| 06/13/2001 | CN1298703A Lubricating cream for copulation and its preparing process |
| 06/13/2001 | CN1298698A Health-care oil for regulating blood fat |
| 06/13/2001 | CN1298697A Spherical lipid powder of tanshinone precursor and its preparing process |
| 06/13/2001 | CN1298647A Health-care oil for regulating blood fat |
| 06/13/2001 | CN1066966C Low melting point and/or volatile active plaster |
| 06/13/2001 | CN1066964C Microcapsules, method of making same and their use |
| 06/13/2001 | CN1066963C Contrast agent and improvement thereof |
| 06/13/2001 | CN1066959C Medicine for treating hydocephalus |
| 06/13/2001 | CN1066958C Anti pruritic aerosol |
| 06/13/2001 | CN1066947C Capsule for treating sexual impotence |
| 06/13/2001 | CN1066944C Ointment for burn and scald |
| 06/13/2001 | CN1066942C Vaginal antiphlogistic powder, and its prepn. method |
| 06/13/2001 | CN1066937C Improved method for mfg. frozen dried dosages in a multilaminate blister pack |
| 06/12/2001 | USRE37224 Immunization of seals |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245808 Oxy-vanadium (IV) complexes having spermicidal activity |
| 06/12/2001 | US6245805 Coadministering a taxane and a cyclosporin |
| 06/12/2001 | US6245803 Palatable elemental medical food |
| 06/12/2001 | US6245788 Using 5-aryl-1,2,4-triadazol-3-yl (thio)urea compound |
| 06/12/2001 | US6245785 Dissolution of triprolidine hydrochloride |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245748 Inhibition of an FGF-binding protein using ribozymes |
| 06/12/2001 | US6245747 Targeted site specific antisense oligodeoxynucleotide delivery method |
| 06/12/2001 | US6245740 Polyol:oil suspensions for the sustained release of proteins |
| 06/12/2001 | US6245568 Human papilloma virus vaccine with disassembled and reassembled virus-like particles |
| 06/12/2001 | US6245384 Applying powdered waxes; tumbling |
| 06/12/2001 | US6245366 Fat-coated encapsulation compositions and method for preparing the same |
| 06/12/2001 | US6245365 Arachidonic acid |
| 06/12/2001 | US6245359 Active agent transport systems |
| 06/12/2001 | US6245358 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
| 06/12/2001 | US6245357 Extended release dosage form |
| 06/12/2001 | US6245356 Mixture of amorphous drug, wetting agent, sustained release excipients and diluents |
| 06/12/2001 | US6245355 Sustained release matrix for high-dose insoluble drugs |
| 06/12/2001 | US6245354 Drug delivery system using galactoxyloglucan |
| 06/12/2001 | US6245353 Mixing with effervescent base |
| 06/12/2001 | US6245352 Pharmaceutical formulation |
| 06/12/2001 | US6245351 Controlled-release composition |
| 06/12/2001 | US6245350 Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process |
| 06/12/2001 | US6245349 Drug delivery compositions suitable for intravenous injection |
| 06/12/2001 | US6245348 Topical, therapeutic composition for external use and method of treatment |
| 06/12/2001 | US6245347 Controlling absorption by controlling temperature |
| 06/12/2001 | US6245346 Pharmaceutical compositions for the sustained release of insoluble active principles |
| 06/12/2001 | US6245340 Method of improving the immune response and compositions therefor |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/12/2001 | US6245320 Inhibition of mucin release from airway goblet cells by polycationic peptides |
| 06/12/2001 | US6245057 Device for treating malignant, tumorous tissue areas |
| 06/12/2001 | US6245052 Methods, systems, and kits for implanting articles |
| 06/12/2001 | US6245042 Fluid delivery device with temperature controlled energy source |
| 06/12/2001 | US6244265 Adhesively applied external nasal strips and dilators containing medications and fragrances |
| 06/12/2001 | CA2241922C Material having a substance protected by deformable standoffs and method of making |
| 06/12/2001 | CA2154590C Phase shift colloids as ultrasound contrast agents |
| 06/12/2001 | CA2149861C Self-tanning cosmetic compositions and methods of using the same |
| 06/12/2001 | CA2125665C Medicaments |
| 06/12/2001 | CA2071408C Tablet for slow release of indapamine after oral administration |
| 06/10/2001 | CA2292247A1 Chronotherapeutic formulations of diltiazem and the administration thereof |
| 06/07/2001 | WO2001040446A1 Pour-on formulations |
| 06/07/2001 | WO2001040429A1 Particulate composite material for controlled release of an active agent |
| 06/07/2001 | WO2001040370A2 Ionically crosslinked hydrogels with adjustable gelation time |
| 06/07/2001 | WO2001040254A1 Reagents for gene transfer |
| 06/07/2001 | WO2001040246A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040243A2 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040240A2 Mono- and disaccharide derivatives |
| 06/07/2001 | WO2001040182A2 Solid pharmaceutical preparation |
| 06/07/2001 | WO2001040169A1 Comminuted form of (s)-2-ethoxy -3-[4-(2- {4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
| 06/07/2001 | WO2001040166A1 Comminuted form of 3-{4-[2-(4-tert-butoxycarbonylaminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic |
| 06/07/2001 | WO2001039836A1 A rapid acting freeze dired oral pharmaceutical composition for treating migraine |
| 06/07/2001 | WO2001039822A1 Device for injection of antiparasitic agents in pets |
| 06/07/2001 | WO2001039815A2 Targeted drug delivery with a cd44 receptor ligand |
| 06/07/2001 | WO2001039812A1 A bioabsorbable drug delivery system |
| 06/07/2001 | WO2001039800A2 Controlled delivery of antigens |
| 06/07/2001 | WO2001039789A1 Carbon dioxide enhancement of inhalation therapy |
| 06/07/2001 | WO2001039774A1 Topical administration of ketotifen |
| 06/07/2001 | WO2001039772A1 Pharmaceutical formulations containing zolmitriptan |
| 06/07/2001 | WO2001039771A1 Use of melatonin for treating androgenetic and diffuse alopecia |
| 06/07/2001 | WO2001039763A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 06/07/2001 | WO2001039762A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system |